Stay updated on Effect of Oral AT1001 in Fabry Disease Clinical Trial
Sign up to get notified when there's something new on the Effect of Oral AT1001 in Fabry Disease Clinical Trial page.

Latest updates to the Effect of Oral AT1001 in Fabry Disease Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA new Genet Med 2021 publication about migalastat-treated Fabry disease was added to the Publications list, and the revision tag was updated to v3.5.4, replacing the prior v3.5.3 entry that included an Erratum.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThis page’s footer revision label was updated from “v3.5.2” to “v3.5.3.” This represents a system/version update rather than a change to the study record content.SummaryDifference0.0%

- Check39 days agoChange DetectedGenet Med publication citation updated to include an Erratum and revised to v3.5.2, replacing the previous v3.5.0 citation.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0. No visible changes to study details or page layout.SummaryDifference0.0%

- Check82 days agoChange DetectedFooter revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check96 days agoChange DetectedThe footer now shows Revision: v3.4.2, replacing Revision: v3.4.1.SummaryDifference0.0%

Stay in the know with updates to Effect of Oral AT1001 in Fabry Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Effect of Oral AT1001 in Fabry Disease Clinical Trial page.